Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PhRMA Launching National Patient Assistance Clearinghouse April 5

Executive Summary

The Pharmaceutical Research & Manufacturers of America's "Partnership for Patient Assistance" clearinghouse for prescription drug support programs will roll out nationwide April 5

You may also be interested in...



ACA Cancellation Notices – From Pharma

The Together Rx drug discount program is shutting down in February, with members told that they may have better options in the new health care exchange. That message unfortunately resonates differently than intended in the current climate of concern about insurers cancelling policies ahead of the exchange launch. But, overall, Big Pharma probably has more reasons than ever to maintain patient assistance programs, at least until the ACA launch shakes out.

PhRMA Patient Assistance Plan Is Template For Future Initiatives – BMS’ Dolan

PhRMA's Partnership for Prescription Assistance could serve as a template for future outreach efforts by the pharmaceutical industry, incoming Chairman Peter Dolan (Bristol-Myers Squibb) suggested

PhRMA Patient Assistance Plan Is Template For Future Initiatives – BMS’ Dolan

PhRMA's Partnership for Prescription Assistance could serve as a template for future outreach efforts by the pharmaceutical industry, incoming Chairman Peter Dolan (Bristol-Myers Squibb) suggested

Related Content

Topics

UsernamePublicRestriction

Register

PS045545

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel